QQ客服 官方微博 反馈留言

	Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy
	Yeying Liu; Yuan Huang; Jie Ding; Nannan Liu; Shuang Peng; Jiangang Wang; Feng Wang; Yingjie Zhang
刊名	Cancer Cell International
	2019
卷号	Vol.19 No.1
关键词	AKT GSK-3β Bcl-xL SC66 Colon cancer
ISSN号	1475-2867
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4733408
专题	湖南大学
作者单位	1.Department of Health Management,The Third Xiangya Hospital, Central South University, College of Biology, Hunan University,Changsha,China 2.Department of Gastroenterology,The Tenth People’s Hospital of Shanghai, Tongji University,Shanghai,China 3.Department of Emergency Surgery,The Second Military Medical University,Shanghai,China 4.Shenzhen Institute, Hunan University,Shenzhen,China
推荐引用方式 GB/T 7714	Yeying Liu,Yuan Huang,Jie Ding,et al. Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy[J]. Cancer Cell International,2019,Vol.19 No.1.
APA	Yeying Liu.,Yuan Huang.,Jie Ding.,Nannan Liu.,Shuang Peng.,...&Yingjie Zhang.(2019).Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy.Cancer Cell International,Vol.19 No.1.
MLA	Yeying Liu,et al."Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy".Cancer Cell International Vol.19 No.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。